Evaluation of Galectin-1 and Galectin-3 Levels in Patients with Bipolar Disorder: is Galectin-3 Associated with Treatment Response?

Overview

Journal Braz J Psychiatry

Specialty Psychiatry

Date 2024 May 20

PMID 38767861

Authors

Meryem Yuksel Aytekin

Aybeniz Civan Kahve

Rabia Nazik Ekinci

Arzu Sakalli Nural

Isik Batuhan Cakmak

Nagihan Ayaz Nayci

Erol Goka

Affiliations

Soon will be listed here.

Abstract

Objective: Galectins (Gal), which have been linked with inflammatory response in the central nervous system, may play an important role in the pathogenesis of bipolar disorder. In this study, we investigated whether serum Gal-1 and Gal-3 levels are related to bipolar disorder.

Methods: Thirty-six patients diagnosed with bipolar disorder were included. C-reactive protein, Gal-1, Gal-3 serum concentrations were evaluated on the first day of hospitalization and the third week of treatment and were compared with 41 healthy controls. Illness severity was evaluated with the Young Mania Rating Scale.

Results: Upon hospitalization, the C-reactive protein levels of bipolar disorder patients were significantly higher than in the third week of treatment or in healthy controls. Gal-1 levels on the first day of hospitalization and the third week of treatment were higher than those of healthy controls.There was no significant difference between patient Gal-3 levels upon hospitalization and those of healthy controls; at the end of the third week of treatment, Gal-3 levels were significantly higher than on the first day of hospitalization.

Conclusion: Our study is the first to show a change in Gal levels after treatment and to evaluate the role of Gal in bipolar disorder. Gal-1 may play a role in the pathophysiology of bipolar disorder. Gal-3 could be a biomarker candidate for assessing treatment response.

Citing Articles

Serum Galectin-3 and IL-6 as Inflammatory Markers in Bipolar Disorder: Insights from Manic and Euthymic Episodes.

Ozkaya A, Gurbuzer N, Tozoglu E, Akyildirim S, Mercantepe F J Clin Med. 2025; 14(3).

PMID: 39941474 PMC: 11818607. DOI: 10.3390/jcm14030803.

References

Niu Z, Yang L, Wu X, Zhu Y, Chen J, Fang Y . The Relationship Between Neuroimmunity and Bipolar Disorder: Mechanism and Translational Application. Neurosci Bull. 2019; 35(4):595-607. PMC: 6617679. DOI: 10.1007/s12264-019-00403-7. View

Goldstein B, Kemp D, Soczynska J, McIntyre R . Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. J Clin Psychiatry. 2009; 70(8):1078-90. DOI: 10.4088/JCP.08r04505. View

Barondes S, Cooper D, Gitt M, Leffler H . Galectins. Structure and function of a large family of animal lectins. J Biol Chem. 1994; 269(33):20807-10. View

Rabinovich G, Liu F, Hirashima M, Anderson A . An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer. Scand J Immunol. 2007; 66(2-3):143-58. DOI: 10.1111/j.1365-3083.2007.01986.x. View

Pinto J, Passos I, Librenza-Garcia D, Marcon G, Schneider M, Conte J . Neuron-glia Interaction as a Possible Pathophysiological Mechanism of Bipolar Disorder. Curr Neuropharmacol. 2017; 16(5):519-532. PMC: 5997869. DOI: 10.2174/1570159X15666170828170921. View

Starossom S, Mascanfroni I, Imitola J, Cao L, Raddassi K, Hernandez S . Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity. 2012; 37(2):249-63. PMC: 3428471. DOI: 10.1016/j.immuni.2012.05.023. View

Brietzke E, Stertz L, Fernandes B, Kauer-SantAnna M, Mascarenhas M, Vargas A . Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord. 2009; 116(3):214-7. DOI: 10.1016/j.jad.2008.12.001. View

Bhat R, Lerea K, Peng H, Kaltner H, Gabius H, Newman S . A regulatory network of two galectins mediates the earliest steps of avian limb skeletal morphogenesis. BMC Dev Biol. 2011; 11:6. PMC: 3042966. DOI: 10.1186/1471-213X-11-6. View

Parikh N, Aalinkeel R, Reynolds J, Nair B, Sykes D, Mammen M . Galectin-1 suppresses methamphetamine induced neuroinflammation in human brain microvascular endothelial cells: Neuroprotective role in maintaining blood brain barrier integrity. Brain Res. 2015; 1624:175-187. PMC: 4630155. DOI: 10.1016/j.brainres.2015.07.033. View

10.

OCallaghan J, Sriram K, Miller D . Defining "neuroinflammation". Ann N Y Acad Sci. 2008; 1139:318-30. DOI: 10.1196/annals.1432.032. View

11.

Kajitani K, Yanagimoto K, Nakabeppu Y . Serum galectin-3, but not galectin-1, levels are elevated in schizophrenia: implications for the role of inflammation. Psychopharmacology (Berl). 2017; 234(19):2919-2927. DOI: 10.1007/s00213-017-4683-9. View

12.

Liu F . Regulatory roles of galectins in the immune response. Int Arch Allergy Immunol. 2005; 136(4):385-400. DOI: 10.1159/000084545. View

13.

Gubert C, Stertz L, Pfaffenseller B, Panizzutti B, Rezin G, Massuda R . Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects. J Psychiatr Res. 2013; 47(10):1396-402. DOI: 10.1016/j.jpsychires.2013.06.018. View

14.

Rosenblat J, McIntyre R . Are medical comorbid conditions of bipolar disorder due to immune dysfunction?. Acta Psychiatr Scand. 2015; 132(3):180-91. DOI: 10.1111/acps.12414. View

15.

Liu F, Rabinovich G . Galectins as modulators of tumour progression. Nat Rev Cancer. 2005; 5(1):29-41. DOI: 10.1038/nrc1527. View

16.

Mari E, Rasouli J, Ciric B, Moore J, Conejo-Garcia J, Rajasagi N . Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis. Eur J Immunol. 2016; 46(7):1783-96. PMC: 4984530. DOI: 10.1002/eji.201546212. View

17.

Wang X, Zhang S, Lin F, Chu W, Yue S . Elevated Galectin-3 Levels in the Serum of Patients With Alzheimer's Disease. Am J Alzheimers Dis Other Demen. 2013; 30(8):729-32. PMC: 10852776. DOI: 10.1177/1533317513495107. View

18.

Rabinovich G, Baum L, Tinari N, Paganelli R, Natoli C, Liu F . Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?. Trends Immunol. 2002; 23(6):313-20. DOI: 10.1016/s1471-4906(02)02232-9. View

19.

Toscano M, Commodaro A, Ilarregui J, Bianco G, Liberman A, Serra H . Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses. J Immunol. 2006; 176(10):6323-32. DOI: 10.4049/jimmunol.176.10.6323. View

20.

Elola M, Wolfenstein-Todel C, Troncoso M, Vasta G, Rabinovich G . Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival. Cell Mol Life Sci. 2007; 64(13):1679-700. PMC: 11136145. DOI: 10.1007/s00018-007-7044-8. View